Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotypic impact of prolonged detectable HIV type 1 RNA viral load after HAART failure in a CRF01_AE-infected cohort.

AIDS research and human retroviruses - 1 Jul 2011

Zolfo Maria, Schapiro Jonathan M, Phan Vichet, Koole Olivier, Thai Sopheak, Vekemans Marc, Fransen Katrien, Lynen Lutgarde

Abstract excerpt

HIV subtype-specific data on mutation type, rate, and accumulation following HAART treatment failure are limited. We studied patterns and accrual of drug resistance mutations in a Cambodian CRF01_AE-infected cohort continuing a virologically failing first-line, nonnucleoside reverse transcriptase inhibitor- (NNRTI-) based, HAART. Between 2005 and 2007, 837 adult HIV-infected patients had regular plasma HIV-1 RNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cambodia

Share to CD4 Lymphocyte Count

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Treatment Failure

Share to Viral Load

Source

Identifiers

PMID: 20854169
DOI: 10.1089/aid.2010.0037

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotypic impact of prolonged detectable HIV type 1 RNA viral load after HAART failure in a CRF01_AE-infected cohort.PMID 20854169Read ↗

Virological failure and HIV-1 drug resistance mutations among naive and antiretroviral pre-treated patients entering the ESTHER program of Calmette Hospital in Cambodia.Semantic proximity Read ↗

Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients.Semantic proximity Read ↗

Accumulation of HIV drug resistance mutations in patients failing first-line antiretroviral treatment in South Africa.Semantic proximity Read ↗

Initiation of HAART in drug-naive HIV type 1 patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients.Semantic proximity Read ↗

Drug Susceptibility and Resistance Mutations After First-Line Failure in Resource Limited SettingsSemantic proximity Read ↗

Low prevalence of drug resistance transmitted virus in HIV Type 1-infected ARV-naive patients in Cambodia.Semantic proximity Read ↗

Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study.Semantic proximity Read ↗

Virological outcomes of a third-line antiretroviral therapy to inform Cambodian public health policy: the ANRS 12374 3DICAM studySemantic proximity Read ↗

Monitoring HIV Viral Load in Resource Limited Settings: Still a Matter of Debate?Semantic proximity Read ↗

Resistance-associated mutations after initial antiretroviral treatment failure in a large cohort of patients infected with HIV-1 subtype CRF01_AE.Semantic proximity Read ↗

Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique.Semantic proximity Read ↗

Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in Nigeria.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.